The overexpression of ERCC1-XPF has been linked with poor responses to chemotherapy in various cancers including NSCLC, squamous cell carcinoma, ovarian cancer and melanoma while low ERCC1-XPF expression observed in testicular cancer has extended overall survival of cancer patients (195, 196). This evidence concerns the gene ERCC1 and ovarian carcinoma.